Chemistry:Tinlarebant
From HandWiki
Tinlarebant is a investigational new drug that is being evaluated to treat dry macular degeneration and Stargardt disease.[1] It is a retinol binding protein 4 antagonist.[2]
References
- ↑ "Tinlarebant - Belite Bio". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800047970.
- ↑ "Retinol binding protein 4 antagonists and protein synthesis inhibitors: Potential for therapeutic development". European Journal of Medicinal Chemistry 226. December 2021. doi:10.1016/j.ejmech.2021.113856. PMID 34547506.
 |  |
